Annual Report On Environmental, Social And Governance Disclosures Related To Sustainability (ESG) And Financial Disclosures Related To Climate Change (TCFD)

The report outlines ibnsina pharma's environmental, social, and governance disclosures for the fiscal year 2025/2026, submitted to the Egyptian Financial Regulatory Authority. The company highlights its transition to alternative energy, including the installation of solar panels that avoided 131.8 tons of CO2 emissions in 2023, and the conversion of delivery vans to electric vehicles. Additionally, ibnsina pharma upgraded its data servers to more energy-efficient models, saving 3 kWh and avoiding 18 to 25 tons of CO2 annually. The report also outlines the company's risk management strategies regarding climate-related impacts on pharmaceutical storage and distribution.